Microparticles, Vector of Genetic Information During HIV Infection
NCT01687452 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2014-09-01
Summary
The aim of the investigators study is to demonstrate in healthy subjects and a cohort of patients infected with HIV, the presence of miRNAs in circulating peripheral blood microparticles (MPs).
Conditions
- HIV,
Interventions
- BIOLOGICAL
-
Blood samples
Sponsors & Collaborators
-
Assistance Publique Hopitaux De Marseille
lead OTHER
Principal Investigators
-
BERNARD BELAIGUES · Assistance Publique hôpitaux de Marseille
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 30 Years
- Max Age
- 50 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-03-31
- Primary Completion
- 2012-03-31
- Completion
- 2012-03-31
Countries
- France
Study Locations
More Related Trials
-
Immune Responses to HIV in Blood Cells in HIV-Infected and HIV-Uninfected Volunteers
NCT00027482 ·Status: COMPLETED
-
Comparing Raltegravir Genital Tract Distribution in HIV-infected Men and Women
NCT00745368 ·Status: COMPLETED ·Phase: NA
-
Metformin Immunotherapy in HIV Infection
NCT02659306 ·Status: COMPLETED ·Phase: PHASE1
-
Active Immunization of Asymptomatic, HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen: A Phase I/II Study of Immunogenicity and Toxicity
NCT00000977 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating the Safety and Immune Response to an HIV Vaccine Boost Following the Administration of Two HIV Vaccines, in HIV-Uninfected, Healthy Adults (Study Extension to HVTN 073/SAAVI 102)
NCT01423825 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Therapeutic Benefit of r-metHuIFN- Gamma in AIDS Patients With Disseminated Mycobacterium Avium-Intracellulare (MAI) Infection: A Multi-Centered Pilot Study
NCT00002037 ·Status: COMPLETED ·Phase: NA
-
Examining the Role of Genetics in Determining the Immune Response to an HIV Vaccine in HIV-Uninfected Adult Twins
NCT01054872 ·Status: COMPLETED ·Phase: PHASE1
-
MK6186 in HIV-1 Infected Patients (MK-6186-007 AM2)
NCT01152255 ·Status: TERMINATED ·Phase: PHASE1
-
A Clinical Trial of PGDM1400 and PGT121 and VRC07-523LS Monoclonal Antibodies in HIV-infected and HIV-uninfected Adults
NCT03205917 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate Effectiveness and Safety of Containing Raltegravir in Naive HIV NON B or B Infected Patients
NCT01162538 ·Status: UNKNOWN
-
Safety and Tolerability of AAV8 Delivery of a Broadly Neutralizing Antibody in Adults Living With HIV: a Phase 1, Dose-escalation Trial
NCT03374202 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Evaluating the Safety, Tolerability, and Effect of a Human Monoclonal Antibody (VRC01) on Markers of HIV Persistence in HIV-Infected Adults Receiving Antiretroviral Therapy (ART)
NCT02411539 ·Status: COMPLETED ·Phase: PHASE1
-
Study of HIV-1 Rgp-160 Administered by Mucosal Routes in Healthy Volunteers
NCT00122564 ·Status: TERMINATED ·Phase: PHASE1
-
Determining an Effective Site (Groin Versus Arm) for Giving HIV Vaccines
NCT00056745 ·Status: COMPLETED ·Phase: PHASE1
-
Immunogenicity and Safety of COVID-19 Vaccine in People Living With HIV
NCT05085145 ·Status: UNKNOWN ·Phase: PHASE4
-
A Safety and Immunogenicity Study of a Plasmid DNA Prime and MVA Boost Vaccine in HIV-1 Infected Adults on ART
NCT01378156 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection
NCT06987318 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Efficacy Study of COVID-19 mRNA Vaccine in Regions With SARS-CoV-2 Variants of Concern
NCT05168813 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluating the Safety and Immune Response of DNA/MVA Vaccines in HIV-1-Infected Young Adults Taking Anti-HIV Medications
NCT01909414 ·Status: WITHDRAWN ·Phase: PHASE1
-
Phase II Study of AGS-004 as an Immunotherapeutic in Antiretroviral Therapy (ART)-Treated Subjects Infected With HIV
NCT00672191 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase I Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160
NCT00000745 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelope Peptides in Patients With Early Human Immunodeficiency Virus Infection
NCT00001386 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Safety, Tolerability and Immunogenicity of a 1-Dose Regimen of MRKAd5 HIV-1 Gag Vaccine Versus the ALVAC_HIV Vaccine (V520-019)
NCT00894114 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection
NCT00004579 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Safety and Immunogenicity Trial of UBI Microparticulate Monovalent HIV-1 MN Peptide Immunogen in HIV-1 Seronegative Human Subjects
NCT00000798 ·Status: COMPLETED ·Phase: PHASE1